Kiniksa Pharmaceuticals International, plc 10-K for FY2023
Kiniksa Pharmaceuticals International, plc (KNSA)
10-K
2024-02-28
For: 2023-12-31
View Original
Added on
April 04, 2026
About this 10-K
Kiniksa Pharmaceuticals International, plc filed this 10-K on February 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $270.26M
- up 22.7% from $220.18M a year earlier
- Net income
- $14.08M
- down 92.3% from net income of $183.36M a year earlier
- Diluted EPS
- $0.20
- down 92.3% from $2.60 a year earlier